The COVID-19 pandemic has left a lasting impact on India’s health landscape, with a notable rise in irritable bowel syndrome (IBS) cases among survivors and the general population. Indian researchers and clinicians are now focusing on the interplay between COVID-19, psychological stress, and gastrointestinal health, as new evidence highlights the unique challenges faced in the country.
COVID-19 and IBS: The Indian Perspective
Recent multicenter studies involving Indian participants have shown that COVID-19 infection significantly increases the risk of developing IBS, with psychological and clinical factors playing a key mediating role. Symptoms such as dyspnea, acid regurgitation, hunger pains, depression, abdominal distention, and increased flatus were found to be strong predictors of post-COVID IBS, especially when these symptoms persisted for months after infection. Depression, in particular, was a significant mediator, suggesting that mental health interventions could help reduce the burden of IBS in post-COVID patients.
Social and Lifestyle Factors in India
The pandemic’s impact on daily life in India—marked by strict lockdowns, long commutes, and changes in work and social patterns—has also influenced IBS trends. Studies involving Indian respondents found that flexible work arrangements and increased family support during lockdowns sometimes helped control IBS symptoms, while lack of social support and increased stress led to worsening symptoms for others. The Asian context, including India, is unique due to longer average commute times and the importance of social relationships in managing chronic conditions like IBS.
Psychological Distress and Gender Differences
Anxiety and depression have emerged as major risk factors for developing IBS after COVID-19, with women in India being particularly vulnerable. The prevalence of functional gastrointestinal disorders, including IBS, was found to be higher among women, and those experiencing anxiety or depression had a significantly increased risk of persistent symptoms.
The Road Ahead
With India’s large population and high COVID-19 caseload, the post-pandemic rise in IBS presents a significant public health challenge. Addressing both psychological and gastrointestinal symptoms through integrated care, mental health support, and lifestyle interventions will be crucial for improving quality of life for millions of Indians in the post-COVID era.
Author Info & Links Section
Dr. Dayaram Yadav, MBBS (KGMU), MD (Internal Medicine), DNB (Gastroenterology), is a Senior Consultant Gastroenterologist, Hepatologist, and Endoscopist at Max Super Speciality Hospital, Lucknow, with over 20 years of experience in the management of gastrointestinal and liver diseases.
Connect & Book Appointments
- Book your appointment at Max Super Speciality Hospital
- Book your appointment at Wellness & Gastric Center
Find Us & Share Feedback
Stay Connected